EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice

Esraa M Zeidan, Sai Aparna Nagarajan, Akylbek Sydykov, Jens Bier, Monika Brosien, Ashraf Taye, Oleg Pak, Hossein A Ghofrani, Ralph Theo Schermuly, Werner Seeger, Norbert Weissmann, Natascha Sommer iD und 1 weitere

Physiological Reports · 2026

DOI: 10.14814/phy2.70804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2026. Verfasst von Esraa M Zeidan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Excellence Cluster Cardio-Pulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Rese…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Organophosphorus Compounds, Hypoxia, Antioxidants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Cardio-Pulmonary Institute (CPI), Deutsche Forschungsgemeinschaft (DFG) and NSF (National Science Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial reactive oxygen species (mtROS) have been implicated in the development of chronic hypoxia‐induced pulmonary hypertension (PH), potentially through hypoxia‐inducible factor‐1α (HIF‐1α) stabilization. However, the role of mtROS in HIF‐1α stabilization, PH development, and the therapeutic potential of antioxidant treatment remains controversial. Mice were exposed to hypoxia (10% O 2 ) for 4 weeks to induce PH and treated with mitochondria‐targeted antioxidant mitoTEMPO or its carrier control, triphenylphosphonium (TPP + ). Cell proliferation was evaluated in mouse pulmonary arterial smooth muscle cells (PASMCs) by BrdU incorporation. HIF‐1α stabilization and downstream target expression were investigated in mouse lung carcinoma epithelial (CMT167) cells and isolated mouse and human PASMCs under different hypoxic conditions. In vivo mitoTEMPO treatment did not affect chronic hypoxia‐induced PH compared to TPP + . In vitro, mitoTEMPO treatment did not inhibit hypoxia‐induced mouse PASMCs proliferation but enhanced proliferation under normoxic conditions. In vitro exposure of CMT167 cells and mouse or human PASMCs to mitoTEMPO or TPP + did not alter HIF‐1α protein levels or expression of its downstream targets lactate dehydrogenase A ( Ldha ) and pyruvate dehydrogenase kinase 1 ( Pdk1 ) under normoxic (21% O 2 ) or hypoxic (1% or 10% O 2 ) conditions after 24 h. These findings do not support a therapeutic benefit of mitoTEMPO in hypoxia‐induced PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryOrganophosphorus CompoundsHypoxiaAntioxidantsAnimalsMaleHypoxia-Inducible Factor 1, alpha SubunitHumansMiceCell ProliferationMyocytes, Smooth MusclePulmonary ArteryMice, Inbred C57BLReactive Oxygen SpeciesPiperidines

Stichwörter der Autor:innen

HIF‐1αchronic hypoxiamitoTEMPOpulmonary hypertension

Substanzen

Organophosphorus CompoundsHypoxia-Inducible Factor 1, alpha SubunitMitoTEMPOAntioxidantsReactive Oxygen SpeciesHif1a protein, mousePiperidines

Autor:innen und Institutionen

  • Excellence Cluster Cardio-Pulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus-Liebig University, Giessen, Germany.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena, Egypt.
  • Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI) Giessen, Giessen, Germany.

ORCID-Profile: Natascha Sommer, Claudio Nardiello

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • Cardio-Pulmonary Institute (CPI)
  • Deutsche Forschungsgemeinschaft (DFG) and NSF (National Science Foundation)
  • National Science Foundation

Zitieren

APA

Zeidan, E. M., Nagarajan, S. A., Sydykov, A., Bier, J., Brosien, M., Taye, A., Pak, O., Ghofrani, H. A., Schermuly, R. T., Seeger, W., Weissmann, N., Sommer, N., & Nardiello, C. (2026). The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice. Physiological Reports. https://doi.org/10.14814/phy2.70804

Vancouver

Zeidan EM, Nagarajan SA, Sydykov A, Bier J, Brosien M, Taye A, et al. The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice. Physiological Reports. 2026. doi:10.14814/phy2.70804

BibTeX
@article{Zeidan2026,
  author = {Zeidan, Esraa M and Nagarajan, Sai Aparna and Sydykov, Akylbek and Bier, Jens and Brosien, Monika and Taye, Ashraf and Pak, Oleg and Ghofrani, Hossein A and Schermuly, Ralph Theo and Seeger, Werner and Weissmann, Norbert and Sommer, Natascha and Nardiello, Claudio},
  title = {The effect of mitoTEMPO on the development of hypoxia‐induced pulmonary hypertension in male mice},
  journal = {Physiological Reports},
  year = {2026},
  doi = {10.14814/phy2.70804}
}
Kostenlos starten →